Editorial Expression of Concern to: Oncogene https://doi.org/10.1038/sj.onc.1208118, published online 11 October 2004
The Editors-in-Chief would like to alert the readers that concerns have been raised regarding highly similar 36 h and 72 h Actin blots in Fig. 7a of this article[1]. The original data are no longer available due to the age of the article. Readers are therefore advised to interpret these results with caution.
Klaus Podar, Kenji Ishitsuka, Constantine Mitsiades, Noopur Raje, Nikhil C Munshi, Paul G Richardson and Kenneth C Anderson agree to this Editorial Expression of Concern. Teru Hideshima, Dharminder Chauhan, Makoto Hamasaki and Tony Navas have not responded to any correspondence from the editor or publisher about this Editorial Expression of Concern. The publisher has not been able to obtain current email addresses for Yu-Tzu Tai, Hiromasa Hideshima, George Schreiner, Aaron N Nguyen, Linda S Higgins
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hideshima, T., Podar, K., Chauhan, D. et al. Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells. Oncogene (2024). https://doi.org/10.1038/s41388-024-03147-5
Published:
DOI: https://doi.org/10.1038/s41388-024-03147-5
